<DOC>
	<DOCNO>NCT00999115</DOCNO>
	<brief_summary>The purpose study determine safety efficacy allogenic eASCs ( expand adult stem cell ) treatment recto-vaginal fistula patient Crohn´s disease .</brief_summary>
	<brief_title>Allogenic Stem Cells Derived From Lipoaspirates Treatment Recto-vaginal Fistulas Associated Crohn ` Disease ( ALOREVA )</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Vaginal Fistula</mesh_term>
	<mesh_term>Rectovaginal Fistula</mesh_term>
	<criteria>Signed informed consent . Patients Crohn´s disease diagnose least 12 month early accordance accept clinical , endoscopic , anatomopathological and/or radiologic criterion . Fulfilling one follow criterion : At least , one previous surgery fistulous disease . Physical status discourage liposuction . Rectovaginal fistula . Women childbearing age . Good general state health accord finding clinical history physical examination . Presence severe proctitis ( prominent friability , spontaneous bleeding , multiple erosion , deep ulcer ) dominant active luminal disease require immediate therapy , assess rectosigmoidoscopy Patients CDAI≥201 Patients abscess unless complete toilet area drainage collection absence abscess collection confirm prior treatment start Patients receive infliximab anti TNF agent 8 week cell treatment administration Patients receive tacrolimus cyclosporine 4 week cell treatment administration Patients history abuse alcohol addictive substance 6 month prior inclusion Patients malignant tumor , except basal cell cutaneous squamous cell carcinoma , patient prior history malignant tumor , unless neoplastic disease remission previous 5 year Patients cardiopulmonary disease , opinion investigator , unstable sufficiently serious exclude patient study . Patients type medical psychiatric disease , opinion investigator , could ground exclusion study Patients congenital acquire immunodeficiency . HIV , HBV , HCV treponema infection , whether active latent . Patients allergic local anesthetic gadolinium ( MRI contrast ) MRI unfeasible ( e.g . due presence pacemaker , hip replacement severe claustrophobia ) Patients suffer major surgery severe trauma prior 6 month Pregnant breastfeed woman Patients currently receive , receive within 1 month prior enrolment clinical trial , investigational drug .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Rectovaginal Fistula</keyword>
	<keyword>Crohn Disease</keyword>
	<keyword>Allogenic</keyword>
	<keyword>Adipose-Derived Stem Cells</keyword>
</DOC>